Services
Online Inquiry
For research use only. Not intended for any clinical use.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Non-Human Primate (NHP) Cardiovascular Disease Model Development Service
Are you currently facing complex challenges in developing new cardiovascular therapies, struggling with the translational gap between preclinical models and human clinical trials, or seeking to de-risk your drug candidates? Our Non-Human Primate (NHP) Cardiovascular Disease Model Development service helps you accelerate your drug discovery and therapeutic development by providing physiologically relevant and predictive in vivo models. Through our advanced model development expertise and a robust preclinical platform, we enable you to obtain reliable data, streamline your research, and move closer to clinical success.
Overview of NHP Cardiovascular Diseases Model Development
What Our Service Is
Our NHP Cardiovascular Disease Model Development service leverages the unique biological and genetic similarities of non-human primates to humans, providing a superior platform for preclinical research. This service involves the establishment and characterization of in vivo NHP models that closely mimic the pathogenesis and progression of human cardiovascular diseases. Key application scenarios for our services include:
- Novel Therapeutic Screening: Testing the efficacy and safety of new drug candidates for diseases such as atherosclerosis and heart failure in a model with high translational relevance.
- Mechanistic Studies: Investigating the underlying biological pathways of cardiovascular diseases and the mechanism of action of new therapies.
- Biomarker Identification: Discovering and validating new biomarkers for disease progression or drug response in a system that mirrors human physiology.
Why Choose Us?
The journey from a promising compound to an approved drug is fraught with challenges, with a significant number of candidates failing in clinical trials due to a lack of efficacy or unforeseen toxicity. This is often a result of relying on preclinical models that do not accurately predict human outcomes. Creative Biolabs addresses this critical pain point by providing highly predictive NHP models.
By choosing Creative Biolabs, you gain access to models that naturally develop age-related cardiovascular comorbidities, eliminating the need for complex genetic manipulation. This value proposition translates directly into a higher probability of clinical success, saving you valuable time and resources. Our models allow for the control of diet, environment, and genetics, enabling more precise studies on gene-by-environment interactions and a deeper understanding of drug effects.
Distributed under Unsplash License, from Unsplash.
Key Benefits of Our Service
Creative Biolabs' NHP Cardiovascular Disease Model Development service is distinguished by several key advantages that can significantly benefit your project. We offer an unparalleled level of precision, speed, and customization to meet the specific demands of your research.
- Exceptional Response Speed: Our streamlined processes and established protocols allow us to respond to your project inquiries and initiate model development with remarkable speed, accelerating your project timelines from day one.
- Extensive NHP Resources: With access to a large, well-characterized colony of diverse NHP species, including Cynomolgus, Rhesus, Marmoset, and African Green Monkey, we can provide the optimal model for your specific disease or research question, ensuring the best fit for your preclinical study.
- Customization: We understand that every research project is unique. We specialize in developing and customizing novel disease models based on your specific requirements, enabling you to study a wider range of cardiovascular pathologies, including complex or rare conditions.
- Reporting Depth: Our comprehensive reporting includes detailed pathological data, imaging results (such as ultrasound and MRI), and histological analyses, providing a holistic view of the disease progression and the therapeutic effect of your compound.
How Creative Biolabs' NHP Model Development Can Assist Your Project?
Creative Biolabs' NHP models are designed to provide clear, actionable insights into your therapeutic candidates. Our expertise in model development and comprehensive analytical capabilities ensure you receive reliable data. Our service provides solutions for critical problems, such as de-risking candidates with potential cardiotoxicity and proving therapeutic efficacy in a model that closely resembles human physiology.
01
Required Starting Materials
02
Project Scoping and Model Selection
03
Model Establishment and Characterization
04
Treatment and Dosing
05
In-Life Assessments and Data Collection
06
Terminal Procedures and Final Analysis
Key Deliverables
- Comprehensive Study Report: A detailed document summarizing the study design, methodology, results, and conclusions.
- Raw Data Files: All original data from physiological measurements, imaging, and biochemical assays.
- Histopathological Analysis Report: Detailed findings from tissue examinations, including microscopic images and annotations.
- Model Annotations: Detailed descriptions and characterization data for each model used in the study.
- Lab Report: Certified results from all laboratory tests, including blood work and biomarker assays.
Capabilities & Partnerships
Service-Specific Data
- Annual Sample Size: Over 50,000 samples analyzed per year.
- Turnaround Time (TAT): Typical turnaround of 2 weeks for bioanalytical results.
- Study Pass Rate: 99%+ success rate in meeting study endpoints.
Our Valued Partners
Frequently Asked Questions
Q: Why are NHP models considered the gold standard for cardiovascular disease research?
A: NHPs are the most physiologically relevant preclinical models because their cardiovascular systems, genetic makeup, and disease progression closely mimic those of humans. This makes them invaluable for studies where data from rodents or other models may not be predictive, significantly reducing the risk of failure in subsequent clinical trials.
Q: Can you develop a model for a specific or rare cardiovascular condition that is not listed on your website?
A: Absolutely. Our team excels at customizing disease models to meet unique research needs. If your project involves a specific or rare condition, please contact us to discuss the development of a tailored model. We have extensive experience in this area.
Q: How does using an NHP model compare to other animal models, such as mice or pigs, for cardiovascular research?
A: While other models can be useful, NHPs provide superior translational value. Unlike mice, NHPs naturally develop a wide range of cardiovascular diseases without genetic manipulation, and their accelerated aging allows for the study of chronic conditions. Their anatomical similarities to humans also make them ideal for surgical and interventional procedures, which is a major advantage over smaller models.
Q: What measures do you take to ensure the ethical and humane treatment of the animals?
A: The welfare and ethical treatment of our animals are our top priorities. We adhere to the highest international standards for animal care. Our facilities are designed to provide an optimal environment, and all procedures are conducted by highly trained and certified veterinary staff.
Q: My project has a tight deadline. How quickly can we begin a study and expect results?
A: We understand the time-sensitive nature of drug development. Once a protocol is finalized, we can typically begin model establishment within a few weeks. The overall project timeline is dependent on the study's length, but our efficient processes and dedicated team ensure we provide you with a detailed report in a timely manner. We encourage you to reach out and discuss your specific timeline with our experts.
Contact Us
Creative Biolabs' NHP Cardiovascular Disease Model Development service provides a critical bridge between preclinical research and clinical success. Our models offer unparalleled translational value, addressing the challenges of drug development with high-quality, reliable, and predictive data. We provide tailored solutions for your unique research needs, supported by our deep expertise, extensive resources, and commitment to scientific excellence. Our team of specialists is ready to discuss your project.